e-learning
resources
Virtual 2021
07.09.2021
Interstitial lung disease around the world
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Evaluation of three dyspnea questionnaires in the progression of Interstitial Lung Diseases.
O. Moran Mendoza (Kingston (ON), Canada), S. Alyami (Riyad, Saudi Arabia), A. Moran-Macdonald (Kingston (ON), Canada), M. Kish (Kingston (ON), Canada), S. Davison (Toronto (ON), Canada)
Source:
Virtual Congress 2021 – Interstitial lung disease around the world
Session:
Interstitial lung disease around the world
Session type:
E-poster
Number:
3751
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
O. Moran Mendoza (Kingston (ON), Canada), S. Alyami (Riyad, Saudi Arabia), A. Moran-Macdonald (Kingston (ON), Canada), M. Kish (Kingston (ON), Canada), S. Davison (Toronto (ON), Canada). Evaluation of three dyspnea questionnaires in the progression of Interstitial Lung Diseases.. 3751
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions
Definition and history of sarcoidosis
Related content which might interest you:
The incidence of Progressive Fibrotic Interstitial Lung Diseases (PFILD) treatable with oral-antifibrotic therapy in a UK Specialist Interstitial Lung Disease clinic.
Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more
Year: 2020
Gender perspective in Interstitial Lung Diseases (ILD)
Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment
Year: 2019
Analysis of children’s diffuse parenchymal lung disease from the European Management Platform for Childhood Interstitial Lung Diseases: Frequency of disease categories and treatments used
Source: International Congress 2017 – Rare diseases
Year: 2017
Tracking crackles of Interstitial Lung Disease during sleep.
Source: International Congress 2018 – Sarcoidosis, interstitial lung diseases and various clinical problems
Year: 2018
Impact of a Bayesian approach on the diagnosis of Interstitial Lung Diseases
Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia
Year: 2019
Usefulness of electronic nose in detection of Interstitial Lung Diseases (ILD)
Source: International Congress 2019 – Biomarkers and beyond in idiopathic interstitial pneumonia
Year: 2019
Autoantibodies in Interstitial Lung Diseases
Source: Virtual Congress 2021 – Biomarkers and e-health in idiopathic interstitial pneumonia
Year: 2021
Translation and preliminary validation of the KBILD QOL questionnaire to Spanish
Source: International Congress 2014 – ILDs 6
Year: 2014
Combined pulmonary fibrosis and emphysema: A report from the Hellenic Interstitial Lung Diseases group
Source: Annual Congress 2010 - Different patterns of interstitial lung disease
Year: 2010
Validation of the King’s Brief Interstitial Lung Disease questionnaire in Danish
Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias
Year: 2018
A Comparison of Pulmonary Rehabilitation Outcomes in Interstitial Lung Disease and Chronic Obstructive Pulmonary Disease
Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases
Year: 2019
Effect of Pulmonary Rehabilitation on Functional Exercise Capacity and Hypoxemia in Patients with Interstitial Lung Diseases: a retrospective study
Source: International Congress 2018 – Aspects of pulmonary rehabilitation and chronic care
Year: 2018
Parasympathetic Nervous System withdrawal in patients with Interstitial Lung Disease but not in COPD patients
Source: International Congress 2018 – Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment
Year: 2018
Translation and validation of the King's brief interstitial lung disease (K-BILD) questionnaire in French, Italian and Dutch
Source: International Congress 2014 – ILDs 2
Year: 2014
Hypersentivity pneumonitis in an Interstitial Lung Disease Unit, 5 years’ experience
Source: Virtual Congress 2020 – Natural history and management of interstitial lung diseases of known cause
Year: 2020
Lung Cancer Screening Programs: a missed “window” to diagnose Obstructive Lung Disease. The NLST-ACRIN experience.
Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms
Year: 2018
Role of Pulmonary Rehabilitation (PR) on clinical care in patients with advance Interstitial Lung Diseases. Does it make any difference?
Source: Virtual Congress 2021 – New approaches to pulmonary rehabilitation and chronic care
Year: 2021
The Role Of TGF-ß in Lung Cancer Development in COPD Patients
Source: Virtual Congress 2020 – Biological mechanisms of lung cancer
Year: 2020
Case Series of COVID-19 Disease in Pediatric Chronic Lung Diseases
Source: Virtual Congress 2021 – Paediatric respiratory infections: chronic infection, vaccination and lung function
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept